Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jules M. Ross, Stéphanie Forté & Denis Soulières. (2022) Emerging drugs for the treatment of sickle cell disease: a review of phase II/III trials. Expert Opinion on Emerging Drugs 27:2, pages 211-224.
Read now
Read now
Ugochi O Ogu, Nnenna U Badamosi, Pamela E Camacho, Amado X Freire & Patricia Adams-Graves. (2021) Management of Sickle Cell Disease Complications Beyond Acute Chest Syndrome. Journal of Blood Medicine 12, pages 101-114.
Read now
Read now
Articles from other publishers (16)
Francine Chenou, Bidossessi Wilfried Hounkpe, Igor de Farias Domingos, Wouitchékpo Vincent Tonassé, Thais Helena Chaves Batista, Rodrigo Marcionilo Santana, Gabriela da Silva Arcanjo, Adekunle Emmanuel Alagbe, Aderson da Silva Araújo, Antonio Roberto Lucena-Araújo, Marcos Andre Cavalcanti Bezerra, Fernando Ferreira Costa, Maria de Fátima Sonati, Erich Vinicius De Paula & Magnun Nueldo Nunes dos Santos. (2021) Effect of hydroxyurea therapy on intravascular hemolysis and endothelial dysfunction markers in sickle cell anemia patients. Annals of Hematology 100:11, pages 2669-2676.
Crossref
Crossref
Caian L. Vinhaes, Rozana S. Teixeira, Jay A. S. Monteiro-Júnior, Rafael Tibúrcio, Juan M. Cubillos-Angulo, María B. Arriaga, Adrielle G. Sabarin, Amâncio J. de Souza, Jacqueline J. Silva, Isa M. Lyra, Ana Marice Ladeia & Bruno B. Andrade. (2020) Hydroxyurea treatment is associated with reduced degree of oxidative perturbation in children and adolescents with sickle cell anemia. Scientific Reports 10:1.
Crossref
Crossref
Steven Holshouser, Rebecca Cafiero, Mayra Robinson, Joy Kirkpatrick, Robert A. CaseroJr.Jr., Hyacinth I. Hyacinth & Patrick M. Woster. (2020) Epigenetic Reexpression of Hemoglobin F Using Reversible LSD1 Inhibitors: Potential Therapies for Sickle Cell Disease. ACS Omega 5:24, pages 14750-14758.
Crossref
Crossref
Jingjing Zhang, Yingqi Mi, Xueqi Sun, Yuan Chen, Qin Miao, Wenqiang Tan, Qing Li, Fang Dong & Zhanyong Guo. (2020) Improved Antioxidant and Antifungal Activity of Chitosan Derivatives Bearing Urea Groups. Starch - Stärke 72:5-6, pages 1900205.
Crossref
Crossref
Inusa, Colombatti, Rees, Heeney, Hoppe, Ogutu, Hassab, Zhou, Yao, Brown, Heath, Jakubowski & Abboud. (2019) Geographic Differences in Phenotype and Treatment of Children with Sickle Cell Anemia from the Multinational DOVE Study. Journal of Clinical Medicine 8:11, pages 2009.
Crossref
Crossref
Jing Li, Si-Yeon Jeong, Bei Xiong, Alan Tseng, Andrew B. Mahon, Steven Isaacman, Victor R. Gordeuk & Jaehyung Cho. (2019) Repurposing pyridoxamine for therapeutic intervention of intravascular cell-cell interactions in mouse models of sickle cell disease. Haematologica 105:10, pages 2407-2419.
Crossref
Crossref
Mahadev Patil, Anurag Noonikara Poyil, Shrinivas D. Joshi, Shivaputra A. Patil, Siddappa A. Patil & Alejandro Bugarin. (2019) Synthesis, molecular docking studies, and antimicrobial evaluation of new structurally diverse ureas. Bioorganic Chemistry 87, pages 302-311.
Crossref
Crossref
Kwesi Nyan Amissah-Arthur & Evelyn Mensah. (2018) The past, present and future management of sickle cell retinopathy within an African context. Eye 32:8, pages 1304-1314.
Crossref
Crossref
Samir K. Ballas. (2018) Sickle cell disease: Classification of clinical complications and approaches to preventive and therapeutic management. Clinical Hemorheology and Microcirculation 68:2-3, pages 105-128.
Crossref
Crossref
Claire L. Anderson & Deepika S. Darbari. 2018. Sickle Cell Disease and Hematopoietic Stem Cell Transplantation. Sickle Cell Disease and Hematopoietic Stem Cell Transplantation
65
86
.
Joep W. R. Sins, David J. Mager, Shyrin C. A. T. Davis, Bart J. Biemond & Karin Fijnvandraat. (2017) Pharmacotherapeutical strategies in the prevention of acute, vaso-occlusive pain in sickle cell disease: a systematic review. Blood Advances 1:19, pages 1598-1616.
Crossref
Crossref
Quan LiEric R. HenryJames HofrichterJeffrey F. SmithTroy CellmerEmily B. DunkelbergerBelhu B. MetaferiaStacy Jones-StraehleSarah BoutomGarrott W. ChristophTerri H. WakefieldMary E. LinkDwayne StatonErica R. VassJeffery L. MillerMatthew M. Hsieh, John F. Tisdale & William A. Eaton. (2017) Kinetic assay shows that increasing red cell volume could be a treatment for sickle cell disease. Proceedings of the National Academy of Sciences 114:5.
Crossref
Crossref
Wanwisa PromsoteFolami Lamoke PowellSatyam VeeanMenaka ThounaojamShanu MarkandAlan SaulDiana GutsaevaManuela BartoliSylvia B. SmithVadivel GanapathyPamela M. Martin. (2016) Oral Monomethyl Fumarate Therapy Ameliorates Retinopathy in a Humanized Mouse Model of Sickle Cell Disease. Antioxidants & Redox Signaling 25:17, pages 921-935.
Crossref
Crossref
Kathryn L. Hassell. (2016) Sickle Cell Disease. American Journal of Preventive Medicine 51:1, pages S1-S2.
Crossref
Crossref
Carlton Dampier, Vaughn Barry, Heather E. Gross, Yang Lui, Courtney D. Thornburg, Darren A. DeWalt & Bryce B. Reeve. (2016) Initial Evaluation of the Pediatric PROMIS? Health Domains in Children and Adolescents With Sickle Cell Disease. Pediatric Blood & Cancer 63:6, pages 1031-1037.
Crossref
Crossref
Joshua P. Gray & Sidhartha D. Ray. 2016. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions
205
210
.